These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33837753)

  • 21. Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation.
    Waks JW; Zimetbaum P
    J Cardiovasc Pharmacol Ther; 2017 Jan; 22(1):3-19. PubMed ID: 27260643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic drug therapy and all-cause mortality after catheter ablation of atrial fibrillation: A propensity-matched analysis.
    Shantha G; Alyesh D; Ghanbari H; Yokokawa M; Saeed M; Cunnane R; Latchamsetty R; Crawford T; Jongnarangsin K; Bogun F; Pelosi F; Chugh A; Morady F; Oral H
    Heart Rhythm; 2019 Sep; 16(9):1368-1373. PubMed ID: 31201962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
    Raatikainen MJ; Hakalahti A; Uusimaa P; Nielsen JC; Johannessen A; Hindricks G; Walfridsson H; Pehrson S; Englund A; Hartikainen J; Kongstad O; Mortensen LS; Hansen PS;
    Int J Cardiol; 2015 Nov; 198():108-14. PubMed ID: 26163901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials.
    Chen W; Liu H; Ling Z; Xu Y; Fan J; Du H; Xiao P; Su L; Liu Z; Lan X; Zrenner B; Yin Y
    PLoS One; 2016; 11(5):e0156121. PubMed ID: 27224469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.
    Camm J
    Int J Cardiol; 2012 Mar; 155(3):362-71. PubMed ID: 21708411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation.
    Willems S; Meyer C; de Bono J; Brandes A; Eckardt L; Elvan A; van Gelder I; Goette A; Gulizia M; Haegeli L; Heidbuchel H; Haeusler KG; Kautzner J; Mont L; Ng GA; Szumowski L; Themistoclakis S; Wegscheider K; Kirchhof P
    Eur Heart J; 2019 Dec; 40(46):3793-3799c. PubMed ID: 31755940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
    Vamos M; Calkins H; Kowey PR; Torp-Pedersen CT; Corp Dit Genti V; Wieloch M; Koren A; Hohnloser SH
    Clin Cardiol; 2020 Mar; 43(3):291-297. PubMed ID: 31872901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of antiarrhythmic drugs during ablation of persistent atrial fibrillation: observations from a large single-centre cohort.
    Lüker J; Sultan A; Sehner S; Hoffmann B; Servatius H; Willems S; Steven D
    Heart Vessels; 2016 Oct; 31(10):1669-75. PubMed ID: 26546306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes Associated with Dronedarone Use in Patients with Atrial Fibrillation.
    Goehring EL; Bohn RL; Pezzullo J; Tave AK; Jones JK; Bozzi S; Tamayo RCSG; Sicignano N; Naccarelli GV
    Am J Cardiol; 2020 Nov; 135():77-83. PubMed ID: 32861738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of medical treatment on long-term results after surgical ablation of atrial fibrillation in cardiac surgical patients.
    Feyrer R; Ballazhi F; Seitz T; Weyand M; Harig F
    Ann Thorac Cardiovasc Surg; 2014; 20(3):207-12. PubMed ID: 23558224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of atrial fibrillation-practical applications for clinical management: if not now, when and how?
    Kany S; Reissmann B; Metzner A; Kirchhof P; Darbar D; Schnabel RB
    Cardiovasc Res; 2021 Jun; 117(7):1718-1731. PubMed ID: 33982075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation.
    Kocheril AG; Calkins H; Sharma AD; Cher D; Stubbs HA; Block JE
    J Interv Card Electrophysiol; 2005 Apr; 12(3):189-97. PubMed ID: 15875109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [What role for antiarrhythmic drugs today in patients with recurrent atrial fibrillation without relevant heart disease?].
    Alboni P
    G Ital Cardiol (Rome); 2015 Nov; 16(11):617-24. PubMed ID: 26571475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic drug therapy for maintaining sinus rhythm early after pulmonary vein ablation in patients with symptomatic atrial fibrillation.
    Sohns C; von Gruben V; Sossalla S; Bergau L; Seegers J; Lüthje L; Vollmann D; Zabel M
    Cardiovasc Ther; 2014 Feb; 32(1):7-12. PubMed ID: 24138075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
    Field ME; Holmes DN; Page RL; Fonarow GC; Matsouaka RA; Turakhia MP; Lewis WR; Piccini JP;
    Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e008961. PubMed ID: 33419385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.
    Dagres N; Varounis C; Flevari P; Piorkowski C; Bode K; Rallidis LS; Tsougos E; Leftheriotis D; Sommer P; Hindricks G; Kremastinos DT
    Am Heart J; 2009 Jul; 158(1):15-20. PubMed ID: 19540387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New evidence: Cryoballoon ablation vs. antiarrhythmic drugs for first-line therapy of atrial fibrillation.
    Andrade JG; Chierchia GB; Kuniss M; Wazni OM
    Europace; 2022 Jun; 24(Suppl 2):ii14-ii21. PubMed ID: 35661868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs.
    Ornelas-Loredo A; Kany S; Abraham V; Alzahrani Z; Darbar FA; Sridhar A; Ahmed M; Alamar I; Menon A; Zhang M; Chen Y; Hong L; Konda S; Darbar D
    JAMA Cardiol; 2020 Jan; 5(1):57-64. PubMed ID: 31774463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials.
    Thind M; Zareba W; Atar D; Crijns HJGM; Zhu J; Pak HN; Reiffel J; Ludwigs U; Wieloch M; Stewart J; Kowey P
    Clin Cardiol; 2022 Jan; 45(1):101-109. PubMed ID: 35019175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.